Update on management of invasive candidiasis

Area of Science:

• Medical Mycology
• Infectious Diseases
• Critical Care Medicine

Background:

• Invasive candidiasis incidence is rising in critically ill and hematologic oncology patients.
• Poor outcomes necessitate improved diagnostic and therapeutic strategies.
• Early detection and treatment significantly impact prognosis.

Purpose of the Study:

• To review current culture-independent diagnostic methods for invasive candidiasis.
• To update therapeutic algorithms based on evidence and guidelines.
• To explore the role of clinical prediction scores and fungal serological markers.

Main Methods:

• Review of current literature on culture-independent microbiological tests.
• Analysis of epidemiological data and risk factors for invasive candidiasis.
• Synthesis of international guidelines for therapeutic approaches.

Main Results:

• Culture-independent tests offer promising diagnostic avenues.
• Combining clinical scores with serological markers can optimize antifungal therapy.
• Updated algorithms provide a framework for managing invasive candidiasis.

Conclusions:

• Early diagnosis and targeted antifungal therapy are key for better patient prognosis.
• Non-culture-based methods and biomarker combinations are vital for timely intervention.
• Evidence-based guidelines are essential for optimizing treatment in high-risk populations.